Vowst denied as not medically necessary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for vowst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Blue Cross Blue Shield Denied Vowst as Not Medically Necessary

Vowst (fecal microbiota, live-jslm) is FDA-approved for the prevention of recurrent Clostridioides difficile (C. diff) infection in adults following antibiotic treatment. A medical-necessity denial from BCBS means the plan's clinical reviewers determined that, based on the information submitted, the criteria set out in BCBS's coverage policy were not met. Common gaps include insufficient documentation of prior C. diff episodes, unclear prior antibiotic treatment history, or missing prescriber attestation of clinical appropriateness.

## Why This Denial Is Appealable

Medical-necessity denials are the most commonly appealed — and among the most commonly overturned — coverage decisions. BCBS's internal reviewers work from a coverage policy checklist; an appeal gives your physician the chance to address every criterion directly.

• Internal appeal: BCBS must conduct a fresh review by a physician in the relevant specialty. Request this explicitly in your appeal letter.
• ACA §2719 external review: If the internal appeal is denied, an independent external reviewer applies clinical standards — not BCBS's internal cost calculus. File within approximately four months of the internal denial.
• ERISA §503 (employer plans): Entitles you to all documents BCBS relied on, including the coverage policy and the reviewer's notes.
• Expedited review: If another C. diff recurrence is imminent or your physician considers delay clinically dangerous, request expedited processing.

## Documentation to Gather

• BCBS's medical-necessity criteria for Vowst: Request the written coverage policy. Read every criterion and confirm your documentation addresses each one.
• C. diff recurrence history: Lab-confirmed (PCR or toxin assay) positive results with dates, the specific antibiotic regimens used for each episode, duration of treatment, and outcome. The number of prior recurrences is a key clinical criterion — document each one precisely.
• Prior antibiotic treatment records: Prescription records and pharmacy fill history showing the antibiotic courses completed before Vowst was prescribed.
• Prescriber medical-necessity letter: The physician must map the patient's history to each of BCBS's coverage criteria explicitly. Vague letters are the most common cause of failed appeals.
• Gastroenterology or infectious disease consultation note: A specialist note (if available) strengthens the case considerably.
• Current clinical status: Chart documentation of the patient's risk factors for further recurrence and why prevention is indicated now.

## Criteria-Mapping Approach

Obtain the exact text of BCBS's Vowst coverage policy. Then construct a table:

| BCBS coverage criterion | Supporting documentation | |---|---| | Confirmed diagnosis of recurrent C. diff | Lab reports with dates | | Prior antibiotic course(s) completed | Prescription and pharmacy records | | Number of prior recurrences meets threshold | Episode log with dates and lab confirmation | | Prescriber attestation of medical necessity | Prescriber letter on letterhead |

Every criterion must be answered. An unanswered criterion is almost always fatal to the appeal.

## Next Step

File a written internal appeal within BCBS's stated deadline. Attach every document listed above. If denied again, request external review immediately — independent reviewers applying clinical standards, rather than plan policy, represent your strongest chance of coverage.